SCORE2
Posted by: Georgia Retina in
Research Title: Study of Comparative Treatments for Retinal Vein Occlusion 2 [SCORE2]: a Multicenter, Prospective, Randomized Non-inferiority Trial of Eyes With Macular Edema Secondary to Central Retinal Vein Occlusion, Comparing Intravitreal Bevacizumab Every 4 Weeks With Intravitreal Aflibercept Every 4 Weeks. Sponsor: The EMMES Corporation Principal Investigator: Robert A Stoltz, M.D., Ph.D. Description: SCORE2 is a multicenter, prospective, randomized, phase…
Read MoreSuprachoroidal Buckling for Retinal Detachment
Posted by: Georgia Retina in
Research Title: Suprachoroidal Buckling Versus Scleral Buckling for the Treatment of Phackic Retinal Detachment Sponsor: Georgia Retina, P.C. Principal Investigator: Jay Stallman, M.D., FACS Description: The purpose of this research study is to compare the new surgical technique, Suprachoroidal buckling, with the established surgical procedures (Pneumatic Retinopexy, Scleral Buckling and Pars Plana Vitrectomy) for retinal detachment repairs. This new…
Read MoreTaiwan Liposome Company (TLC) TLC399A2002
Posted by: Georgia Retina in
Research Title: A Phase IIa Trial of TLC399 (ProDex) in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO): A Double-masked, Randomized Trial to Evaluate Efficacy and Tolerability Sponsor: Taiwan Liposome Company (TLC) Principal Investigator: Robert Stoltz, M.D., PhD Description: Subjects with macular edema will be screened and eligible subject will be enrolled to receive a single dose…
Read MoreXcenda C-01-17 ForeseeHome
Posted by: Georgia Retina in
Research Title: A Retrospective Chart Review Study Evaluating Patients Using the ForseeHome Monitoring Device as Part of Clinical Practice Sponsor: Xcenda, L.L.C Principal Investigator: Michael Jacobson, M.D. Description: The objective of this study is to evaluate the ocular characteristics at the time of clinic examination prompted by a ForeseeHome (FSH) alert in intermediate age-related macular degeneration (AMD) patients testing…
Read MoreRoche BP 30099 BOULEVARD
Posted by: Georgia Retina in
Research Title: A Multiple-Center, Multiple-Dose and Regimen, Randomized, Active Comparator Controlled, Double-Masked, Parallel Group, 36 Week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RG7716 Administered Intravitreally in Patients With Choroidal Neovascularization Secondary to Age-Related Macular Degeneration. Sponsor: Hoffmanm-La Roche Principal Investigator: Jay Stallman, M.D., F.A.C.S. Description: This study will evaluate the safety, tolerability, pharmacokinetics, and efficacy…
Read MoreRoche GX29176 CHROMA
Posted by: Georgia Retina in
Research Title: A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration (CHROMA) Sponsor: Hoffmann-La Roche Principal Investigator: Robert A. Stoltz, M.D., Ph.D. Description: This study is a Phase III, double-masked, multicenter, randomized, sham injection-controlled study evaluating the efficacy and safety of lampalizumab administered by intravitreal injections in…
Read MoreRoche GX30191 OMASPECT
Posted by: Georgia Retina in
Research Title: A Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of Lampalizumab in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration Who Have Completed a Roche-Sponsored Study Sponsor: Hoffman La-Roche Principal Investigator: Robert Stoltz, M.D., PhD Description: This multicenter open-label extension study is designed to evaluate the safety and tolerability of lampalizumab intravitreal injections…
Read MoreSAILOR FVF3689g
Posted by: Georgia Retina in
Research Title: A Study to Evaluate Ranibizumab in Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD) Sponsor: Genentech Principal Investigator: Jay Stallman, M.D. Description: This is a Phase IIIb, single-masked, 1-year multicenter study of the safety and tolerability of intravitreally administered ranibizumab in subjects with active subfoveal CNV secondary to AMD. Start Date: November 2005 Recruitment: Completed Project…
Read MoreSCORE
Posted by: Georgia Retina in
Research Title: The Standard Care vs. COrticosteroid for Retinal Vein Occlusion (SCORE) Study Sponsor: Allergan/NEI/National Institute for Health (NIH) Principal Investigator: Mark Rivellese, M.D. Description: To compare the effectiveness and safety of standard care to intravitreal injection(s) of triamcinolone for treating macular edema (swelling of the central part of the retina) associated with central retinal vein occlusion (CRVO) and…
Read MoreOcriplasmin Research to Better Inform Treatment (ORBIT)
Posted by: Georgia Retina in
Research Title: This is a multicenter, prospective, observational, Phase 4 study that will assess clinical outcomes and safety of JETREA® administered in a real-world setting for the treatment of symptomatic vitreomacular adhesion (VMA) by assessing anatomical and functional outcomes in 1500 patients recruited across approximately 120 USA retina sites. Sponsor: ThromboGenics Principal Investigator: Michael Jacobson, M.D. Description: The sites…
Read More